CD34+/CD38−acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells-Reference-Cited by-同舟云学术

CD34+/CD38−acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells

Published:2012-10-30 Issue:9 Volume:132 Page:2006-2019
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Nishioka Chie,Ikezoe Takayuki,Furihata Mutsuo,Yang Jing,Serada Satoshi,Naka Tetsuji,Nobumoto Atsuya,Kataoka Sayo,Tsuda Masayuki,Udaka Keiko,Yokoyama Akihito

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference49 articles.

1. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell;Bonnet;Nat Med,1997

2. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice;Lapidot;Nature,1994

3. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117);Blair;Exp Hematol,2000

4. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-;Blair;Blood,1998

5. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells;Clarke;Cancer Res,2006

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondria in oral cancer stem cells: Unraveling the potential drug targets for new and old drugs;Life Sciences;2023-10

2. The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML;Blood Advances;2023-03-31

3. Clinical Application of Biomarkers for Hematologic Malignancies;Biomarkers in Medicine;2022-08-30

4. Role of Metastasis Suppressor KAI1/CD82 in Different Cancers;Journal of Oncology;2021-07-09

5. The Context-Dependent Impact of Integrin-Associated CD151 and Other Tetraspanins on Cancer Development and Progression: A Class of Versatile Mediators of Cellular Function and Signaling, Tumorigenesis and Metastasis;Cancers;2021-04-21